Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells

Original language	English
Article number	112515
Journal	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Volume	146
DOIs	https://doi.org/10.1016/j.biopha.2021.112515
Publication status	Published - Feb 2022

ID: 20801101

Generic Portal